CareLINK vs MiniMed

HIPAA secure call center and answering service replacement and communications suite with automatically transcribed visual voicemail, shielded outbound calling, on-call schedule management, full audio and text record capture with retrievability, secure photos from patients, and more.... Mission critical with push notifications plus options for email, text, and pager alerts. Replaces multiple partial solutions in one single, workflow driven platform. Note: Only works for customers with a current, active subscription through Callidus Health, LLC.

Manage your diabetes therapy with the MiniMed™ app! The MiniMed app connects to your MiniMed Flex™ pump system, letting you monitor glucose, adjust insulin delivery, and receive real-time alerts — all from your smartphone. View trends, track daily history, and get reminders for important actions. A new approach to making diabetes management simpler. The app guides you through the startup process and provides an overview of data received from the MiniMed Flex pump and sensor. The MiniMed app is your primary source of information about your therapy and for controlling insulin delivery. Your data is automatically uploaded to CareLink™ software, simplifying the process of sharing information with your healthcare team and care partners. Important: The MiniMed app is only compatible with the MiniMed Flex system, it does not work with other MiniMed pumps. The MiniMed app should only be used with supported mobile devices and operating systems. To access the list of the supported mobile devices and operating systems, go to https://www.medtronicdiabetes.com/app-check The MiniMed Flex system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed Flex system includes SmartGuard technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera Sync™ sensor and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP. MiniMed Flex system is for type 1 ages 7 and over and type 2 ages 18 and over. Prescription required. WARNING: Do not use SmartGuard™ feature for people who require less than 8 units or more than 250 units of insulin/day. For additional safety information and user guides, see https://bit.ly/MiniMedRisks. WARNING: Do not use the MiniMed Flex system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed Flex system. Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed Flex system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including user guides and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, see https://bit.ly/MiniMedRisks. ©2026 MiniMed. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. ™*Third-party brands are trademarks of their respective owners. All other brands are trademarks of the MiniMed company.